1. Home
  2. Analysis
  3. Cefdinir
  4. Kaletra

Cefdinir and Kaletra drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cefdinir (cefdinir) and Kaletra (lopinavir; ritonavir). Common drug interactions include emotional distress among females and emotional distress among males.

The phase IV clinical study analyzes what interactions people have when they take Cefdinir and Kaletra. It is created by eHealthMe based on reports of 33 people who take the same drugs from the FDA, and is updated regularly.

What is Cefdinir?

Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,210 Cefdinir users. Check the latest studies of Cefdinir.

What is Kaletra?

Kaletra has active ingredients of lopinavir; ritonavir. It is often used in hiv infection. eHealthMe is studying from 23,070 Kaletra users. Check the latest studies of Kaletra.

On Jul, 19, 2026

33 people who take Cefdinir and Kaletra together, and have interactions are studied.

Cefdinir and Kaletra drug interactions.

What are the common drug interactions of Cefdinir and Kaletra, by gender? *:

female:

  1. Emotional distress
  2. Pain
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Bone density decreased
  6. Chronic kidney disease
  7. Renal failure (kidney dysfunction)
  8. Fatigue (feeling of tiredness)
  9. Decreased activity
  10. Osteopenia (a condition where bone mineral density is lower than normal)

male:

  1. Emotional distress
  2. Pain
  3. Quality of life decreased
  4. Renal failure (kidney dysfunction)
  5. Bone density decreased
  6. Ankle fracture
  7. Bone disorder
  8. Bone loss
  9. Diffuse mesangial sclerosis (nephrotic syndrome in the infantile and childhood period)
  10. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)

What are the common drug interactions of Cefdinir and Kaletra, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Bone density decreased
  4. Decreased activity
  5. Emotional distress
  6. Pain
  7. Quality of life decreased
  8. Renal disorder (kidney disease)
  9. Renal failure (kidney dysfunction)

20-29:

  1. Renal disorder (kidney disease)
  2. Renal failure (kidney dysfunction)
  3. Blood creatinine increased
  4. Dysstasia (difficulty in standing)
  5. Fatigue (feeling of tiredness)
  6. Gait disturbance
  7. Renal impairment (severely reduced kidney function)
  8. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  9. Anxiety
  10. Bone density decreased

30-39:

  1. Chronic kidney disease
  2. Emotional distress
  3. Osteoporosis (bones weak and more likely to break)
  4. Pain

40-49:

  1. Emotional distress
  2. Pain
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Anxiety
  5. Bone density decreased
  6. Bone loss
  7. Chronic kidney disease
  8. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  9. Fracture
  10. Hip fracture

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Renal failure (kidney dysfunction)
  6. Decreased activity
  7. Depression
  8. Osteopenia (a condition where bone mineral density is lower than normal)
  9. Chronic kidney disease
  10. Fatigue (feeling of tiredness)

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Decreased activity
  4. Fracture
  5. Hyperparathyroidism secondary (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium-secondary)
  6. Kyphosis (a condition of over-curvature of the thoracic vertebrae (upper back))
  7. Mobility decreased (ability to move is reduced)
  8. Nephropathy (damage to or disease of a kidney)
  9. Pneumonia
  10. Quality of life decreased

What are the existing conditions these people have? *

  1. Hiv Infection: 32 people, 96.97%
  2. Infection: 5 people, 15.15%
  3. Pain: 4 people, 12.12%
  4. Nausea (feeling of having an urge to vomit): 4 people, 12.12%
  5. Depression: 4 people, 12.12%
  6. Stress And Anxiety: 4 people, 12.12%
  7. High Blood Pressure: 3 people, 9.09%
  8. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 9.09%
  9. Upper Respiratory Tract Infection: 2 people, 6.06%
  10. Fungal Infection: 2 people, 6.06%

* Approximation only. Some reports may have incomplete information.

Do you take Cefdinir and Kaletra?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cefdinir and Kaletra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cefdinir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Kaletra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefdinir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Kaletra and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on cefdinir and lopinavir; ritonavir (the active ingredients of Cefdinir and Kaletra, respectively), and Cefdinir and Kaletra (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.